The Mark H Zangmeister Center, Columbus
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Hilliard · 10マイル先

18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

被験者募集中第1/2相

Clinical Study Site, Columbus

18歳以上 · 全性別 · 2026/09/10更新 · NCT07335497

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

被験者募集中第3相

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus

18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

被験者募集中第1相

Ohio State University Hospital, Columbus

18歳以上 · 全性別 · 2026/09/08更新 · NCT06561685

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

被験者募集中第2相

Ohio State University Comprehensive Cancer Center, Columbus

18歳以上 · 全性別 · 2026/09/04更新 · NCT06311214

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

被験者募集中第1相

Ohio State University Comprehensive Cancer Center, Columbus

18歳以上 · 全性別 · 2026/08/24更新 · NCT05687136

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

被験者募集中第2相

Ohio State University, Columbus

18歳以上 · 全性別 · 2026/08/21更新 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

被験者募集中第1相

The Ohio State University (OSU), Columbus

18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

被験者募集中第1相

Ohio State University Comprehensive Cancer Center, Columbus

18歳以上 · 全性別 · 2026/08/03更新 · NCT05687110

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

被験者募集中第3相

Research Site, Columbus
Research Site, Hilliard · 10マイル先

18歳以上 · 女性 · 2026/07/29更新 · NCT07044336

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

被験者募集中第1相

The Ohio State University Comprehensive Cancer Center, Columbus

18歳以上 · 男性 · 2026/07/09更新 · NCT07103018

A Study of LY4175408 in Participants With Advanced Cancer

被験者募集中第1相

The Ohio State University (OSU) Wexner Medical Center, Columbus

18歳以上 · 全性別 · 2026/06/23更新 · NCT07046923

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

被験者募集中第1/2相

OSU Brain & Spine Hospital, Columbus

12歳以上 · 全性別 · 2026/05/27更新 · NCT05384626

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

被験者募集中第3相

Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus

18歳以上 · 全性別 · 2026/05/18更新 · NCT06757634

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

被験者募集中第3相

Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus

18歳以上 · 全性別 · 2026/04/09更新 · NCT06064877

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

被験者募集中第2/3相

The Ohio State University, Columbus

全年齢 · 全性別 · 2026/04/02更新 · NCT06581406

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

被験者募集中第1相

OSU Brain and Spine Hospital, Columbus

18歳以上 · 全性別 · 2026/02/25更新 · NCT06521554

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

被験者募集中第3相

The Ohio State University Comprehensive Cancer Center, Columbus

18歳以上 · 全性別 · 2026/02/06更新 · NCT06127407

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

被験者募集中観察研究

Massive Bio SYNERGY-AI site, Columbus

全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

他の都市における転移性癌の試験

Columbusにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。